Bank Of New York Mellon Corp Accelerate Diagnostics, Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.46 - $0.77 $6,615 - $11,074	14,382 New	14,382 $10.1 Million
Q4 2022 Feb 14, 2023	BUY	$0.51 - $17.1 $7,334 - $245,915	14,381 New	14,381 $10,000
Q3 2022 Nov 14, 2022	SELL	$1.01 - $17.0 $18,591 - $312,919	-18,407 Reduced 56.14%	14,381 $22,000
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.41 $41,135 - $107,409	-76,177 Reduced 69.91%	32,788 $33,000
Q1 2022 May 11, 2022	BUY	$1.4 - $5.15 $8,906 - $32,764	6,362 Added 6.2%	108,965 $156,000
Q4 2021 Feb 11, 2022	SELL	$4.27 - $6.97 $15,807 - $25,802	-3,702 Reduced 3.48%	102,603 $536,000
Q3 2021 Nov 12, 2021	BUY	$5.31 - $8.25 $16,710 - $25,962	3,147 Added 3.05%	106,305 $619,000
Q2 2021 Aug 11, 2021	SELL	$6.81 - $9.23 $113,597 - $153,965	-16,681 Reduced 13.92%	103,158 $831,000
Q1 2021 May 13, 2021	SELL	$7.99 - $15.0 $183 - $345	-23 Reduced 0.02%	119,839 $997,000
Q4 2020 Feb 09, 2021	SELL	$7.04 - $11.7 $81,431 - $135,333	-11,567 Reduced 8.8%	119,862 $908,000
Q3 2020 Nov 12, 2020	SELL	$9.98 - $18.04 $8,872 - $16,037	-889 Reduced 0.67%	131,429 $1.4 Million
Q2 2020 Aug 12, 2020	BUY	$7.49 - $15.16 $86,606 - $175,295	11,563 Added 9.58%	132,318 $2.01 Million
Q1 2020 May 06, 2020	BUY	$4.62 - $18.74 $7,595 - $30,808	1,644 Added 1.38%	120,755 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$14.6 - $18.13 $76,212 - $94,638	5,220 Added 4.58%	119,111 $2.01 Million
Q3 2019 Nov 07, 2019	SELL	$16.62 - $23.92 $22,237 - $32,004	-1,338 Reduced 1.16%	113,891 $2.11 Million
Q2 2019 Aug 12, 2019	SELL	$17.79 - $22.88 $99,072 - $127,418	-5,569 Reduced 4.61%	115,229 $2.64 Million
Q1 2019 May 14, 2019	BUY	$11.76 - $22.15 $4,327 - $8,151	368 Added 0.31%	120,798 $2.54 Million
Q4 2018 Feb 11, 2019	SELL	$10.42 - $21.94 $7,283 - $15,336	-699 Reduced 0.58%	120,430 $1.39 Million
Q3 2018 Nov 09, 2018	SELL	$20.4 - $24.6 $69,727 - $84,082	-3,418 Reduced 2.74%	121,129 $0
Q2 2018 Aug 06, 2018	SELL	$19.02 - $24.95 $113,891 - $149,400	-5,988 Reduced 4.59%	124,547 $2.78 Million
Q1 2018 May 15, 2018	BUY	$22.55 - $29.9 $48,257 - $63,986	2,140 Added 1.67%	130,535 $2.98 Million
Q4 2017 Feb 09, 2018	BUY	$18.0 - $30.0 $2.31 Million - $3.85 Million	128,395	128,395 $3.36 Million

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $115M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account